Arcturus Therapeutics's total assets for Q1 2025 were $331.79M, a decrease of -3.57% from the previous quarter. ARCT total liabilities were $98.03M for the fiscal quarter, a -4.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.